Formation Bio
Formation Bio (formerly TrialSpark) is a New York pharmaceutical company that acquires and in-licenses clinical-stage drug candidates, many of them stalled or shelved by their original owners, and uses AI and centralised clinical operations to develop them faster before licensing them to large drugmakers.
Analytics date: 09.11.2026
Basic information
Head office
16 East 34th Street, Floor 10, New York, NY 10016, United StatesHead officeGeography of business
United States of AmericaGeography of businessDate of the last round
Last round 06/2024Date of the last roundTotal funds raised
$615.8M+Total funds raisedPrice per share
$8.18Price per sharePrice per share. Based on the latest known transaction. It is not an offer or investment recommendation.
Analytics date: 09.11.2026
IPO Forecast
No IPO plans announced.
With no plans for further venture rounds and a new fund for pipeline growth, Formation is set up to grow privately. A listing would most likely follow clinical or licensing success.
Request price
Competitor Analysis
Comparison with other companies in the industry.
| Name | Valuation |
| Private companies | |
AI21 Labs | 000 |
Stability AI | 0000 |
Databricks | 00000 |
ThoughtSpot | 000 |
OpenAI | 00 |
| Traded companies | |
Baidu | 00000 |
Amazon Web Services | 00000 |
AeroVironment | 00 |
Alphabet | 00 |
Microsoft Corporation | 00 |
| Acquired companies | |
xAI | 00000 |